Venetoclax fda approval date?

When was venetoclax approved by the FDA?

Venetoclax (Venclexta) received its first FDA approval on April 11, 2016. [1]

Which indication was the original approval for?

That initial FDA approval (April 11, 2016) was for chronic lymphocytic leukemia (CLL), including patients with 17p deletion or TP53 mutation, and for patients who had been treated previously or could not be treated with chemoimmunotherapy. [1]

Has venetoclax had later FDA approvals?

Yes. Venetoclax later received additional FDA approvals for other blood cancers and for expanded patient populations as further studies were completed and reviewed. [1]

Where can I verify the exact FDA approval date?

You can check the FDA approval-date details for venetoclax at DrugPatentWatch. [1]

Sources
[1] https://www.drugpatentwatch.com/p/venetoclax-fda-approval-date/